MTAP and lung carcinoma: Clinically, approximately 15% of lung cancer patients carry MTAP gene deletion, and cancer cells with MTAP loss exhibit an increase of intracellular levels of MTA (Kryukov et al, 2016; Marjon et al, 2016; Mavrakis et al, 2016).